The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJun 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Although taking care of the adult incontinence condition is considered crucial in preserving dignity and quality of life, in 2019 remedying products were still not included in the Colombian Health Benefits Plan (PBS). It is believed to be only a matter of time, however, before they are covered by the Plan and therefore healthcare companies (EPSs) will need to provide these items upon receipt of a health practitioner’s prescription.
In 2019, pharmacies within hospitals and clinics were visibly increasing the shelf space for adult incontinence products, considering that these products were provided by neither hospitals and clinics nor by healthcare insurance companies. Despite its wide distribution network, leading brand manufacturer Productos Familia Sancela SA still regards Farmacia La Rebaja as an important online channel to increase the penetration of adult incontinence products, especially among families with mid-range incomes.
As previously mentioned, in 2019 adult incontinence products were still outside of the Health Benefits Plan, which contains the list of technologies, supplies and medicines that are provided by the healthcare system against a medical prescription. The reimbursement of adult incontinence is covered by FOSYGA (Fondo de Solidaridad y Garantía), a fund created by Law 100 of 1993, which is the basis of the current healthcare system in Colombia and dedicated to cover catastrophic health or personal events and traffic accidents.
In 2020, sales of Rx/reimbursement adult incontinence are expected to grow by 2% in 2019 constant value terms, factoring in the impact of COVID-19.
COVID-19 is likely to have little impact on Rx/reimbursement adult incontinence, with the channel’s supply regulated by healthcare providers, which are less vulnerable to demand surplus than retailers.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement Adult incontinence industry in Colombia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement Adult incontinence industry in Colombia, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement Adult incontinence in Colombia market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.